Skip to main content
. 2019 Oct 24;13(2):dmm041434. doi: 10.1242/dmm.041434

Fig. 2.

Fig. 2.

Comparison of the goals and expertise provided by academic and industry partners. Shown is the relationship between academia and industry. Goals and expertise for academia (yellow) and industry (blue) are highlighted. Combined expertise for drug development with input from technology transfer offices (TTOs), patient organizations and clinical trial support (green) may result in marketing approval and increased accessibility for patients. The goals and expertise listed are not mutually exclusive and may be applicable to both academia and industry. PKPD, pharmacokinetics/pharmacodynamics; CMC, chemistry, manufacturing, control.